Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM)...

Corinium presents: Data & Analytics in Healthcare Online ASEAN

Join Corinium's Data and Analytics in Healthcare ASEAN on October 18 and learn how healthcare can use data and analytics to revolutionise patient experience....

HMA conference to look at future of Hospital at Home model in Asia

With limited hospital capacity and growing demand for care, Hospital at Home (HaH) programmes have gained traction over the world as an alternative care...

Mediwelcome Announced 2022 Interim Results

 Continuously expanding the medical digital marketing solutions and online healthcare platforms Seizing the growth opportunities to create greater value A China's leading provider of...

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

Offer Price at HK$16.16 per Offer Share AIM Vaccine Co., Ltd. (AIM Vaccine or the Company, together with its subsidiaries, the Group, HKG: 6660),...

Malaysian Genomics Grows Presence in Thailand

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to...

Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah

Parties agree to collaborate on research in genetics, regenerative and alternative medicine Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155)...

Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene...

Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell &...

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

Global markets in sight for shariah-compliant IndoVac vaccine brand PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new...
Avance Clinical

Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling biotech...

Oculis announces publication and presentation of Phase 2 data showing topical OCS-01 improves macular...

Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the Phase...

Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in...

Meet the team at Booth #409 Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new data showing Asia...

Legend Capital: The Logic of Technology Investment Has Changed 

Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market...

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in...

Transcenta Holding (06628): Product pipeline progressing well with significant competitive differentiation

As pharmaceutical reformation is underway, the importance of the innovative strength of biotech companies has become increasingly prominent, the entire industry has also formed...

Universal Medical (2666.HK) Announces 2022 Interim Results

Pursuing Progress in Revenue, Increased by 14.1% Ensuring Stability and Accommodating the Needs for Pandemic Control The board of directors of Genertec Universal Medical...

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding...

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global...

Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results

Application Scenario Solutions Open Up Broad New Prospects in Assisted Reproduction Suzhou Basecare Medical Corporation Limited (Basecare Medicalor the Company, together with its subsidiaries,...
Avance Clinical

Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards...

Avance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards - Biotech Company of the Year Private and Public - at...

Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening...

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of...